The successful treatment of melasma by subthermolytic Q-Switched Nd:YAG laser therapy has
been demonstrated by several investigators. The
minimization of side-effects and reoccurence in high
phototype patients is a major topic of current research.
The approaches taken and the results obtained are
reviewed in this paper.